Literature DB >> 7423155

[5'-deoxy-5-fluoruridine, a new antineoplastic pyrimidine antimetabolite].

H R Hartmann, W Bollag.   

Abstract

5'-deoxy-5-fluorouridine (5-DFUR) exerts a marked cytostatic activity, both intraperitoneally and orally, against experimental tumors. It has a strong antitumor effect on the Crocker sarcoma S 180, the Lewis lung carcinoma and a chemically induced squamous cell carcinoma of the skin. Its ratio of antitumor activity toxicity is more favourable than that of 5-fluorouracil, 2'-deoxy-5-fluorouridine and 1-(2-tetra-hydrofuryl)-5-fluorouracil. Mode of action and reasons for the favourable therapeutic ratio are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7423155

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

1.  Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion.

Authors:  P A Reece; I N Olver; R G Morris; J F Bishop; T W Guentert; H S Hill; B L Hillcoat
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.

Authors:  H R Hartmann; W Bollag
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.

Authors:  H J Kang; H M Chang; T W Kim; M-H Ryu; H-J Sohn; J H Yook; S T Oh; B S Kim; J-S Lee; Y-K Kang
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.